An article in Banyan Hill discussed a better way to buy Vitamins. A company called Baze, prides themselves on being the only FDA approved at-home blood nutrient test. They are aiming to take the guesswork out of nutrition supplements by using your DNA to customize vitamins that are optimum for your body.
One way to take advantage of the continued advances of DNA-Specific health is through an ETF called Ark Genomic Revolution ETF (NYSE: ARKG).
The ETF is up 300% over the past few years and 50% of that over the past few months. With holdings like Inovo Pharmaceuticals (NYSE: INO), Sorrento Therapeutics (NASDAQ: SRNE) and Tracon Pharmaceuticals (NASDAQ: TCON), and Ocugen, Inc. (NASDAQ: OCGN), It’s hard not to believe it.
But, surprisingly missing in this ETF is exposure to the diabetic space.
Take a look at Glucose Health, Inc. (OTC Pink: GLUC). The Company manufacturers nutritional beverages for the diabetic-adult nutrition consumer retail category under the registered trademark GLUCODOWN®. GLUCODOWN® is infused with a special form of diabetic fiber demonstrated in more than 20 clinical studies to help maintain healthy blood sugar levels and regular digestive health.
During the 2nd quarter, Glucose Health, Inc. experienced unprecedented consumer demand for GLUCODOWN® – in particular at Amazon.com (NASDAQ: AMZN). By mid-June it became apparent to management that GLUCODOWN® inventories at Amazon were rapidly depleting and the Company responded quickly by placing new production orders. Other retailers distributing GLUCODOWN® include CVS Health (NYSE: CVS), Walmart (NYSE: WMT).
What are the revenues of this company going to look like when the latest GLUCODOWN® sales numbers are reported for Q3 and Q4?
Over the past 12 months, GLUC has seen a range of approximately $.20 – $1.90 per share and with only 12.5 million shares outstanding, GLUC could be the best value in the diabetes space and should be on everybody’s watch list.
EmergingGrowth.com is a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth markets and companies. Through its evolution, EmergingGrowth.com found a niche in identifying companies that can be overlooked by the markets due to, among other reasons, trading price or market capitalization. We look for strong management, innovation, strategy, execution, and the overall potential for long- term growth. Aside from being a trusted resource for the Emerging Growth info-seekers, we are well known for discovering undervalued companies and bringing them to the attention of the investment community. Through our parent Company, we also have the ability to facilitate road shows to present your products and services to the most influential investment banks in the space.